Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03944902
Title CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients (BRCA)
Acronym BRCA
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.